Astellas Pharma Market Cap

Astellas Pharma has a market cap or net worth of $17.12 billion as of January 22, 2025. Its market cap has decreased by -18.69% in one year.

Market Cap

17.12B

Enterprise Value

21.25B

Revenue

12.37B

Ranking

n/a

PE Ratio

44.79

Stock Price

$9.48

Market Cap Chart

Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 17.12B, an increase of 145.82%. That is a compound annual growth rate of 2.76%.

Market Cap History

Date	Market Cap	% Change
Jan 22, 2025	16.99B	-2.78%
Dec 30, 2024	17.48B	-18.50%
Dec 29, 2023	21.44B	-22.67%
Dec 30, 2022	27.73B	-7.87%
Dec 30, 2021	30.10B	5.02%
Dec 30, 2020	28.66B	-10.92%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.02B
Veradigm	1.53B
SS Innovations International	1.45B
Nika Pharmaceuticals	603.98M
Elite Pharmaceuticals	539.48M
Glass House Brands	414.24M
Northwest Biotherapeutics	378.71M
BioStem Technologies	261.80M

Market Cap Rankings